Aurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded by StockNews.com to Strong-Buy Rating
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday. Aurinia Pharmaceuticals Price Performance Shares of AUPH stock opened at $8.29 on Thursday. The business’s fifty day moving average is $8.09 […]
More Stories
Corebridge Financial Inc. Purchases 2,483 Shares of Alkami Technology, Inc. (NASDAQ:ALKT)
Corebridge Financial Inc. increased its position in Alkami Technology, Inc. (NASDAQ:ALKT – Free Report) by 10.4% during the fourth quarter,...
Alphabet Inc. (NASDAQ:GOOGL) Stock Position Increased by Parametrica Management Ltd
Parametrica Management Ltd increased its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 8.8% in the 4th...
Anthracite Investment Company Inc. Buys 6,000 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Anthracite Investment Company Inc. increased its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 85.7% in the...
JPMorgan Chase & Co. Reduces Position in Sonos, Inc. (NASDAQ:SONO)
JPMorgan Chase & Co. trimmed its position in Sonos, Inc. (NASDAQ:SONO – Free Report) by 6.6% during the fourth quarter,...
Innovative Industrial Properties, Inc. (NYSE:IIPR) Shares Sold by Corebridge Financial Inc.
Corebridge Financial Inc. lowered its stake in shares of Innovative Industrial Properties, Inc. (NYSE:IIPR – Free Report) by 7.2% in...
Corebridge Financial Inc. Sells 2,442 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)
Corebridge Financial Inc. cut its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 5.5% in the...